Occlutech granted important conditional FDA approval for PFO S...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SCHAFFHAUSEN, Switzerland, Aug. 16, 2021 /PRNewswire-AsiaNet/ -- Occlutech Holding AG ("Occlutech"), one of the world's leading providers of minimally invasive structural heart disease devices, announces the conditional U.S. Food and Drug Administration ("FDA") approval of its Investigational Device Exemption (...
Authors: LATEST ASIANET NEWS RELEASES